Showing results (11-20 of 169) with videos related to
Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
CCR 20th anniversary commentary: Radioactive Drones for B-cell lymphomaSusan J Knox, Ronald LevyCancer Research|May 31, 2002
In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphomaJavier Briones, John Timmerman, Ronald LevyOncoimmunology|January 23, 2015
New insights into the mechanism of action of immune checkpoint antibodiesAurélien Marabelle, Holbrook Kohrt, Ronald LevyProceedings of the National Academy of Sciences of the United States of America|April 27, 2016
Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodiesJames Torchia, Kipp Weiskopf, Ronald LevyClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2013
Intratumoral anti-CTLA-4 therapy: enhancing efficacy while avoiding toxicityAurélien Marabelle, Holbrook Kohrt, Ronald LevyBlood|May 10, 2003
BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphomaTakashi Akasaka, Izidore S Lossos, Ronald LevyBlood|October 13, 2006
Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapyWen-Kai Weng, Debra Czerwinski, Ronald LevyBlood Advances|September 9, 2018
Enhancing immunotherapy of STING agonist for lymphoma in preclinical modelsAdrienne Sallets, Sophie Robinson, Adel Kardosh, et al.The Journal of Physical Chemistry. B|February 10, 2026
Toward Reconciling the Standard Binding Free Energy of Lenacapavir to HIV-1 Capsid with Experiment: Thermodynamic Effects of Solvent Buffer and Ligand ReorganizationQinfang Sun, Emilio Gallicchio, Ronald Levy, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
TCR vaccines against a murine T cell lymphoma: a primary role for antibodies of the IgG2c class in tumor protectionStacie L Lambert, Craig Y Okada, Ronald LevyPageof 17